Completed

Phase 3
Age: 18Years +
All Genders
ID00001017

Comparison of Fluconazole (UK-49,858) and Amphotericin B for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome

Led by Pfizer · Updated on 2011-03-14

330

Participants Needed

28

Research Sites

N/A

Total Duration

On this page

Sponsors

P

Pfizer

Lead Sponsor

N

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsor

AI-Summary

What this Trial Is About

To compare the safety and effectiveness of a new drug, fluconazole, with that of the usual therapy, amphotericin B, in the prevention of a relapse of cryptococcal meningitis (CM) in patients with AIDS who have been successfully treated for acute CM in the last 6 months. Cryptococcal meningitis is a life-threatening infectious complication of AIDS. Because relapse after treatment occurs in over 50 percent of cases, chronic maintenance therapy with intravenous (IV) amphotericin B is usually given. However, amphotericin B is not always effective, has toxic effects, and must be given by the intravenous route. Fluconazole is an antifungal agent that can be given orally and has been shown to be effective against cryptococcal infections in animals and against acute CM in a few AIDS patients. Also, the side effects experienced by over 2000 patients or volunteers given fluconazole have seldom been severe enough to require withdrawal of the drug.

CONDITIONS

Official Title

Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Inclusion Criteria

  • HIV infection documented by antibody (ELISA on two occasions or ELISA with Western blot confirmation), p24 antigen testing, or recovery of HIV in culture.

Prior Medication:

Required:

  • Minimum total dose of 15 mg/kg of amphotericin B (either alone or in combination with flucytosine) during primary therapy. End of primary therapy within 6 weeks of start of maintenance therapy.
  • Allowed:
  • Past or present antiviral therapy and prophylaxis for Pneumocystis carinii pneumonia (PCP).
  • Pfizer must be notified if the patient is receiving ganciclovir at entry. Allowed with amphotericin B to treat or prevent side effects.
  • Antipyretics.
  • Hydrocortisone.
  • Meperidine.

Exclusion Criteria

Co-existing Condition:

Patients with the following are excluded:

  • Clinical evidence of acute or chronic meningitis other than cryptococcosis.
  • Allergy or intolerance of imidazoles, azoles, or amphotericin B. Unable to take oral medications reliably.

Patients with the following are excluded:

  • Clinical evidence of acute or chronic meningitis other than cryptococcosis.
  • Allergy or intolerance of imidazoles, azoles, or amphotericin B.

Prior Medication:

Excluded for more than 7 days after initiation of primary therapy for cryptococcosis:

  • Ketoconazole.
  • Fluconazole.
  • Itraconazole.
  • Miconazole.
  • Any other systemic imidazole or azole.
  • Excluded:
  • Intrathecal amphotericin B.
  • Coumadin-type anticoagulants.
  • Oral hypoglycemics.
  • Barbiturates.
  • Phenytoin.
  • Immunostimulants.
  • Investigational drug or approved (licensed) drugs for investigational indications.

Prior Treatment:

Excluded:

  • Lymphocyte replacement.
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 28 locations

1

UCLA CARE Ctr

Los Angeles, California, United States, 90095

Status Unknown

2

Univ of Miami School of Medicine

Miami, Florida, United States, 331361013

Status Unknown

3

Indiana Univ Hosp

Indianapolis, Indiana, United States, 462025250

Status Unknown

4

Louisiana State Univ School of Medicine

New Orleans, Louisiana, United States, 70112

Status Unknown

5

Tulane Univ School of Medicine

New Orleans, Louisiana, United States, 70112

Status Unknown

6

Johns Hopkins Hosp

Baltimore, Maryland, United States, 21287

Status Unknown

7

Harvard (Massachusetts Gen Hosp)

Boston, Massachusetts, United States, 02114

Status Unknown

8

Beth Israel Deaconess - West Campus

Boston, Massachusetts, United States, 02215

Status Unknown

9

SUNY / Erie County Med Ctr at Buffalo

Buffalo, New York, United States, 14215

Status Unknown

10

City Hosp Ctr at Elmhurst / Mount Sinai Hosp

Elmhurst, New York, United States, 11373

Status Unknown

11

Beth Israel Med Ctr / Peter Krueger Clinic

New York, New York, United States, 10003

Status Unknown

12

Bellevue Hosp / New York Univ Med Ctr

New York, New York, United States, 10016

Status Unknown

13

Cornell Univ Med Ctr

New York, New York, United States, 10021

Status Unknown

14

Mem Sloan - Kettering Cancer Ctr

New York, New York, United States, 10021

Status Unknown

15

Saint Luke's - Roosevelt Hosp Ctr

New York, New York, United States, 10025

Status Unknown

16

Mount Sinai Med Ctr

New York, New York, United States, 10029

Status Unknown

17

Univ of Rochester Medical Center

Rochester, New York, United States, 14642

Status Unknown

18

SUNY - Stony Brook

Stony Brook, New York, United States, 117948153

Status Unknown

19

Jack Weiler Hosp / Bronx Municipal Hosp

The Bronx, New York, United States, 10465

Status Unknown

20

Montefiore Med Ctr / Bronx Municipal Hosp

The Bronx, New York, United States, 10467

Status Unknown

21

North Central Bronx Hosp / Bronx Municipal Hosp

The Bronx, New York, United States, 10467

Status Unknown

22

Bronx Veterans Administration / Mount Sinai Hosp

The Bronx, New York, United States, 10468

Status Unknown

23

Univ of North Carolina

Chapel Hill, North Carolina, United States, 275997215

Status Unknown

24

Duke Univ Med Ctr

Durham, North Carolina, United States, 27710

Status Unknown

25

Holmes Hosp / Univ of Cincinnati Med Ctr

Cincinnati, Ohio, United States, 452670405

Status Unknown

26

Univ Hosp of Cleveland / Case Western Reserve Univ

Cleveland, Ohio, United States, 44106

Status Unknown

27

Ohio State Univ Hosp Clinic

Columbus, Ohio, United States, 432101228

Status Unknown

28

Julio Arroyo

West Columbia, South Carolina, United States, 29169

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

N/A

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

M S Saag, W G Powderly, G A Cloud...

https://pubmed.ncbi.nlm.nih.gov/1727236

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.

W G Powderly, M S Saag, G A Cloud...

https://pubmed.ncbi.nlm.nih.gov/1538722

Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.

W G Powderly, G A Cloud, W E Dismukes...

https://pubmed.ncbi.nlm.nih.gov/8075272

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.

R E McKinney, M A Maha, E M Connor...

https://pubmed.ncbi.nlm.nih.gov/1672443